Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTACT 2: Gefitinib with Paclitaxel and Carboplatin in Advanced NSCLC
NCT00006049Phase 3Unknown
- Sponsor
- AstraZeneca
- Start
- May 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gefitinib in non-small cell lung cancer (NSCLC), sponsored by AstraZeneca. Status: unknown.
02
Drugs
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00006049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006049.